A standard FDA 21 CFR Part 11 approach helps organizations secure electronic records and maintain digital integrity. These controls are essential for ensuring data authenticity, traceability, and regulatory acceptance in regulated manufacturing environments.

However, in the QMSR era, digital compliance alone is no longer sufficient. Regulators increasingly expect proof that electronic records accurately reflect what is happening on the physical shop floor, not just within systems.

While an FDA 21 CFR part 11 compliance checklist confirms that electronic signatures and records are properly managed, LocaXion highlights that it does not verify whether inventory and processes align with physical reality. This gap can create compliance risk during inspections.

By extending compliance strategies to include real-time location intelligence and Digital Twin technology, organizations can bridge the divide between digital records and physical inventory. This approach provides verifiable proof of control and strengthens overall audit readiness.